XCUR logo

Exicure (XCUR) Company Overview

Profile

Full Name:

Exicure, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 22, 2018

Indexes:

Not included

Website:

http://www.exicuretx.com

Description:

Exicure (XCUR) is a biotechnology company focused on developing innovative therapies using its unique DNA-based technology. They aim to treat various diseases, including genetic disorders and cancer, by delivering targeted treatments that can improve patient outcomes and enhance the effectiveness of existing therapies.

Key Details

Price

$10.10

Market Cap

$21.94 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$10.55(-276.79% YoY)

PE Ratio

-

Annual ROE

-558.03%

Annual Debt To Equity

2.20

Beta

1.38

Events Calendar

Earnings

Next earnings date:

Jun 17, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 27, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 28, 2024

Analyst ratings

Recent major analysts updates

Aug 16, 22 Chardan Capital
Neutral
Dec 13, 21 Chardan Capital
Neutral
Nov 23, 21 Chardan Capital
Buy
May 17, 21 HC Wainwright & Co.
Buy
Dec 18, 20 BMO Capital
Outperform
Sep 17, 20 Chardan Capital
Buy
Nov 20, 19 Guggenheim
Buy
Nov 6, 19 H.C. Wainwright
Buy
Mar 26, 19 Chardan Capital
Buy
Jul 11, 18 Ladenburg Thalmann
Buy

Screeners with XCUR included

Growing Shares Outstanding
US stocks
Stocks with high beta
Biggest stock losers today
Stocks recommended to hold
Best performing stocks last 3 months
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$10.10
XCUR price is $10.10

Price All-time High

$975.00
XCUR price is currently -98.96% below its historical high of $975.00

Price Analysts Target

-
XCUR price consensus analysts' forecast is unknown

Price Most Recent Change

-11.4%
XCUR price was down -11.4% on Feb 7, 2025

Price YTD Change

-19.2%
XCUR price is down -19.2% since January 1st

Price 3-Year Change

-64.75%
XCUR price is down -64.75% over the past 3 years

Market cap

Market Cap

$21.94 M
XCUR market capitalization is $21.94 million

Market Cap 3-Year Change

+5.6%
XCUR market capitalization is up +5.6% over the past 3 years

Market Cap All-time High

$288.21 M
XCUR market capitalization is currently -92.39% below its historical high of $288.21 million

Market Cap Sector Rank

25.55%
XCUR market capitalization is higher than 25.55% of companies in Healthcare sector

Technical

Beta

1.38
XCUR beta is 1.38

200-day SMA

$5.82
XCUR price is currently +73.53% above its 200-day simple moving average

14-day RSI

45.05
XCUR 14-day relative strength index is 45.05

30-day Relative Volume

0.12
XCUR 30-day relative volume is 0.12

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
XCUR annual revenue value is unknown

Annual Revenue Analysts Estimate

-
XCUR annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
XCUR annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
XCUR annual revenue is unknown

Profit

Annual Gross Profit

-
XCUR annual gross profit value is unknown

Annual Gross Margin

-
XCUR annual gross profit margin value is unknown

Annual Operating Profit

-$14.08 M
XCUR annual operating income is -$14.08 million

Annual Operating Margin

-
XCUR annual operating profit margin value is unknown

Annual Net Income

-$16.91 M
XCUR annual net profit is -$16.91 million

Annual Net Margin

-
XCUR annual net profit margin value is unknown

EPS

Annual EPS

-$10.55
XCUR annual earnings per share is -$10.55

Annual EPS Analysts Estimate

-
XCUR annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-276.79%
XCUR annual earnings per share is down -276.79% year-on-year

Annual EPS Sector Rank

14.33%
XCUR annual earnings per share is higher than 14.33% of companies in Healthcare sector

ROA & ROE

Annual ROA

-146.06%
XCUR annual return on assets is -146.06%

Annual ROE

-558.03%
XCUR annual return on equity is -558.03%

EBIT & EBITDA

Annual EBIT

-$16.91 M
XCUR annual earnings before interest & taxes is -$16.91 million

Annual EBITDA

-$15.54 M
XCUR annual EBITDA is -$15.54 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
XCUR price to earnings ratio value is unknown

PE Ratio Sector Rank

-
XCUR price to earnings ratio is unknown

PB Ratio

PB Ratio

14.20
XCUR price to book ratio is 14.20

PB Ratio Sector Rank

93.87%
XCUR price to book ratio is higher than 93.87% of companies in Healthcare sector

PS Ratio

PS Ratio

-
XCUR price to sales ratio value is unknown

PS Ratio Sector Rank

-
XCUR price to sales ratio is unknown

Enterprise value

Enterprise Value

$27.73 M
XCUR enterprise value is $27.73 million

Enterprise Value Sector Rank

31.96%
XCUR enterprise value is higher than 31.96% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.72
XCUR EV/EBITDA is -8.72

EV/EBITDA Sector Rank

16.15%
XCUR EV/EBITDA is higher than 16.15% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.81
XCUR annual current ratio is 0.81

Annual Quick Ratio

-
XCUR annual quick ratio value is unknown

Leverage

Annual Debt To Equity

2.20
XCUR annual debt to equity ratio is 2.20

Annual Interest Coverage Ratio

-
XCUR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
XCUR piotroski f-score value is unknown

Altman Z-Score

-
XCUR altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$11.58 M
XCUR annual total assets is $11.58 million

Annual Non Current Assets

$9.56 M
XCUR annual long term assets is $9.56 million

Annual Current Assets

$2.02 M
XCUR annual total current assets is $2.02 million

Annual Cash & Cash Equivalents

$816.00 K
XCUR annual cash & cash equivalents is $816.00 thousand

Equity

Annual Book Value

$3.03 M
XCUR annual book value is $3.03 million

Annual Working Capital

-$486.00 K
XCUR annual working capital is -$486.00 thousand

Liabilities

Annual Total Liabilities

$8.55 M
XCUR annual total liabilities is $8.55 million

Annual Total Long Term Liabilities

$6.04 M
XCUR annual total long term liabilities is $6.04 million

Annual Current Liabilities

$2.51 M
XCUR annual total current liabilities is $2.51 million

Annual Accounts Payable

$1.63 M
XCUR annual accounts payable is $1.63 million

Debt

Annual Total Debt

$6.67 M
XCUR annual total debt is $6.67 million

Annual Total Debt 1-Year Change

-8.77%
XCUR annual total debt is down -8.77% year-on-year

Annual Long Term Debt

$6.04 M
XCUR annual long term debt is $6.04 million

Annual Short Term Debt

$626.00 K
XCUR annual short term debt is $626.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$14.08 M
XCUR annual total expenses is $14.08 million

Annual Operating Expenses

$14.08 M
XCUR annual total operating expenses is $14.08 million

Annual Cost Of Goods Sold

-
XCUR annual cost of goods sold value is unknown

Annual SGA

$12.65 M
XCUR annual SGA is $12.65 million

Annual D&A

$1.38 M
XCUR annual depreciation & amortization is $1.38 million

Annual Interest Expense

$0.00
XCUR annual interest expense is $0.00

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$10.36 M
XCUR annual cash flow from operations is -$10.36 million

Annual CFO 1-Year Change

+70.95%
XCUR annual cash flow from operations is up +70.95% year-on-year

Annual CFI

-$1.08 M
XCUR annual cash flow from investing activities is -$1.08 million

Annual CFI 1-Year Change

-122.96%
XCUR annual cash flow from investing activities is down -122.96% year-on-year

Annual CFF

$3.67 M
XCUR annual cash flow from financing activities is $3.67 million

Annual CFF 1-Year Change

+218.33%
XCUR annual cash flow from financing activities is up +218.33% year-on-year

Free CashFlow

Annual FCF

-$10.36 M
XCUR annual free cash flow is -$10.36 million

Annual FCF 1-Year Change

+70.96%
XCUR annual free cash flow is up +70.96% year-on-year

CAPEX

Annual CAPEX

-
XCUR annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
XCUR annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

IBO logo
Impact BioMedical (IBO)
TRIB logo
Trinity Biotech (TRIB)
LSTA logo
Lisata Therapeutics (LSTA)
Gelteq Limited (GELS)
CODX logo
Co-Diagnostics (CODX)
ITRM logo
Iterum Therapeutics (ITRM)
HOOK logo
HOOKIPA Pharma (HOOK)
CCM logo
Concord Medical Services Holdings Limited (CCM)
NXGL logo
NEXGEL (NXGL)
CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
XCUR
businesswire.comJanuary 23, 2025

CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics, Inc.

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
XCUR
businesswire.comDecember 26, 2024

CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Partners with GPCR Therapeutics Inc. to Fuel New Growth in Biotech.

CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
XCUR
businesswire.comDecember 21, 2024

CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes.

Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
XCUR
businesswire.comDecember 20, 2024

CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes.

Why Is Exicure (XCUR) Stock Down 27% Today?
Why Is Exicure (XCUR) Stock Down 27% Today?
Why Is Exicure (XCUR) Stock Down 27% Today?
XCUR
investorplace.comJuly 22, 2024

Exicure (NASDAQ: XCUR ) stock is dropping on Monday after the prior early-stage pharmaceutical company's shares underwent a rally on Friday. That rally resulted in shares of XCUR stock rising 76% higher during normal trading hours.

Why Is Exicure (XCUR) Stock Up 57% Today?
Why Is Exicure (XCUR) Stock Up 57% Today?
Why Is Exicure (XCUR) Stock Up 57% Today?
XCUR
InvestorPlaceDecember 8, 2023

Exicure (NASDAQ: XCUR ) stock is rising higher on Friday despite a lack of news from the early-stage biotechnology company. Exicure hasn't released any recent press releases or made any filings that would result in today's stock rally.

FAQ

  • What is the ticker symbol for Exicure?
  • Does Exicure pay dividends?
  • What sector is Exicure in?
  • What industry is Exicure in?
  • What country is Exicure based in?
  • When did Exicure go public?
  • Is Exicure in the S&P 500?
  • Is Exicure in the NASDAQ 100?
  • Is Exicure in the Dow Jones?
  • When was Exicure's last earnings report?
  • When does Exicure report earnings?
  • Should I buy Exicure stock now?

What is the ticker symbol for Exicure?

The ticker symbol for Exicure is NASDAQ:XCUR

Does Exicure pay dividends?

No, Exicure does not pay dividends

What sector is Exicure in?

Exicure is in the Healthcare sector

What industry is Exicure in?

Exicure is in the Biotechnology industry

What country is Exicure based in?

Exicure is headquartered in United States

When did Exicure go public?

Exicure's initial public offering (IPO) was on May 22, 2018

Is Exicure in the S&P 500?

No, Exicure is not included in the S&P 500 index

Is Exicure in the NASDAQ 100?

No, Exicure is not included in the NASDAQ 100 index

Is Exicure in the Dow Jones?

No, Exicure is not included in the Dow Jones index

When was Exicure's last earnings report?

Exicure's most recent earnings report was on Nov 14, 2024

When does Exicure report earnings?

The next expected earnings date for Exicure is Jun 17, 2025

Should I buy Exicure stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions